Terug
Dagbereik
€ 104,96
€ 109,00
52-Weeksbereik
€ 7,58
€ 120,32
Volume
503.645
50D / 200D Gem.
€ 109,41
/
€ 69,66
Vorige Slotkoers
€ 106,04
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -44,2 | 0,4 |
| P/B | 42,7 | 2,9 |
| ROE % | -87,5 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,9 | 0,2 |
Koersdoel Analisten
Hold
€ 108,75
+1.9%
Low: € 77,00
High: € 126,00
Forward WPA
-€ 4,02
Omzet Sch.
55 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 7,32
€ 2,68 – € 12,94
|
1 B | 4 |
| FY2028 |
€ 3,64
€ 2,26 – € 5,29
|
700 M | 6 |
| FY2027 |
-€ 0,30
-€ 3,18 – € 4,65
|
360 M | 9 |
Belangrijkste Punten
Negative free cash flow of -83,72M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-87,54%
ROIC-39,78%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,85
Current Ratio7,71
Interest Coverage-11,02
Waardering
P/E Ratio
-44,19
P/B Ratio42,72
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -111,78M |
| ROE | -87,54% | ROA | -45,60% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -83,72M |
| ROIC | -39,78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,85 | Current Ratio | 7,71 |
| Interest Coverage | -11,02 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -44,19 | P/B Ratio | 42,72 |
| P/S Ratio | N/A | PEG Ratio | -0,89 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,94B | Enterprise Value | 5,01B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -111,78M | -63,78M | -40,37M | -29,61M | -9,47M |
| EPS (Diluted) | -2,83 | -2,69 | -2,68 | -2,28 | -0,89 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -113,27M | -66,23M | -39,39M | -28,36M | -9,56M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 245,12M | 191,22M | 175,70M | 85,91M | 12,96M |
| Total Liabilities | 129,50M | 51,45M | 41,93M | 17,20M | 1,25M |
| Shareholders' Equity | 115,62M | 139,77M | 133,77M | 68,71M | 11,70M |
| Total Debt | 97,95M | 37,45M | 35,24M | 14,89M | 262.488,0 |
| Cash & Equivalents | 22,51M | 30,66M | 24,57M | 84,29M | 11,64M |
| Current Assets | 244,57M | 190,59M | 175,16M | 85,35M | 12,17M |
| Current Liabilities | 31,72M | 14,19M | 6,88M | 2,51M | 1,19M |